197 related articles for article (PubMed ID: 325016)
1. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
2. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
Zubler RH; Lange G; Lambert PH; Miescher PA
J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
[TBL] [Abstract][Full Text] [Related]
3. The nature of immune complexes in human cancer sera.
Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor.
Mackel SE; Tappeiner G; Brumfield H; Jordan RE
J Clin Invest; 1979 Dec; 64(6):1652-60. PubMed ID: 500831
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
6. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
7. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.
Brandeis WE; Helson L; Wang Y; Good RA; Day NK
J Clin Invest; 1978 Dec; 62(6):1201-9. PubMed ID: 748375
[TBL] [Abstract][Full Text] [Related]
9. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.
Lew PD; Zubler R; Vaudaux P; Farquet JJ; Waldvogel FA; Lambert PH
J Clin Invest; 1979 Feb; 63(2):326-34. PubMed ID: 429556
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes in systemic lupus erythematosus.
Cano PO; Jerry LM; Sladowski JP; Osterland CK
Clin Exp Immunol; 1977 Aug; 29(2):197-204. PubMed ID: 302768
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in Indian childhood cirrhosis.
Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.
Lurhuma AZ; Cambiaso CL; Masson PL; Heremans JF
Clin Exp Immunol; 1976 Aug; 25(2):212-26. PubMed ID: 954232
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney.
Ooi YM; Ooi BS; Vallota EH; First MR; Pollak VE
J Clin Invest; 1977 Sep; 60(3):611-9. PubMed ID: 330564
[TBL] [Abstract][Full Text] [Related]
17. [Circulating immune complexes and necrotizing vasculitis].
Tappeiner G; Wolff K
Hautarzt; 1979 Dec; 30(12):628-33. PubMed ID: 398359
[TBL] [Abstract][Full Text] [Related]
18. Immune complexes and antibodies to BCG in sera from patients with mycobacterial infections.
Carr RI; Chakraborty AK; Brunda MJ; Davidson PT; Damle PB; Hardtke MA; Gilbride KJ; Minden P
Clin Exp Immunol; 1980 Mar; 39(3):562-9. PubMed ID: 6991170
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in onchocerciasis.
Paganelli R; Ngu JL; Levinsky RJ
Clin Exp Immunol; 1980 Mar; 39(3):570-5. PubMed ID: 7379329
[TBL] [Abstract][Full Text] [Related]
20. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
